S J Houston - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Breast Cancer Research and Treatment|March 12, 2011

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancerR Coleman, E Woodward, J Brown, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trialA N Serafini, S J Houston, I Resche, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trialP G Corrie, A Marshall, P D Nathan, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Breast Cancer Research and Treatment|March 12, 2011

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancerR Coleman, E Woodward, J Brown, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trialA N Serafini, S J Houston, I Resche, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trialP G Corrie, A Marshall, P D Nathan, et al.

Pageof 2